4Mendelsohn J,Baselga J.Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer.J Clin Oncol,2003,21(14):2787-2799.
5Stamatakos M,Ch S,Tsaknaki S,et al.Primary adenocarcinoma of the appendix:an update.Chirurgia (Bucur),2009,104(4):389-392.
6Delektorskaya VV,Chemeris GY,Kononets PV,et al.Clinical significance of hyperexpression of epidermal growth factor receptors (EGFR and HER-2) in esophageal squamous cell carcinoma.Bull Exp Biol Med,2009,148(2):241-245.
7Hama T,Yuza Y,Saito Y,et al.Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.Oncologist,2009,14(9):900-908.
8Meche A,Cimpean AM,Raica M.Immunohistochemical expression and significance of epidermal growth factor receptor (EGFR) in breast cancer.Rom J Morphol Embryol,2009,50(2):217-221.
9Tanaka K,Otake K,Mohri Y,et al.Clinical significance of the gene expression profile in residual tumor cells after neoadjuvant chemo-radiotherapy for esophageal cancer.Oncol Rep,2009,21(6):1489-1494.
10Keizman D,Issakov J,Meller I,et al.Expression and significance of EGFR in malignant peripheral nerve sheath tumor.J Neurooncol,2009,94(3):383-388.
